Founders Fund V Management, LLC

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Founders Fund V Management, LLC reported 4 stock positions worth $1.1 million. Its top holding was Cyclo Therapeutics (CYTH) at 61.1% of the portfolio, followed by Nova (NVMI, 19.1%) and Rigetti Computing (RGTI, 12.4%). Compared with Q4 2023, it opened 1 new position. The biggest buy was a new position in Nova (NVMI).

Most Recent 13F
Q4 2025
Location
SAN FRANCISCO, CA
CIK
0001697733
Portfolio Value
$1.1M (Q1 2024)
SEC Filing
0001085146-24-002620 ↗ filed May 15, 2024

Holdings Value

0$1.0M$2.0M$3.0M Q1 2024: $1.1M $1.1M Q1 2024 Q2 2024: $846K Q2 2024 Q3 2024: $572K Q3 2024 Q4 2024: $1.7M Q4 2024 Q1 2025: $1.1M Q1 2025 Q2 2025: $1.4M Q2 2025 Q3 2025: $2.9M Q3 2025 Q4 2025: $2.2M Q4 2025

Holdings 4 stocks · $1.1M
CYTH Cyclo Therapeutics Inc. 61.13% 480,708 $668K No change
NVMI Nova Ltd. 19.09% 117,924 $209K New
RGTI Rigetti Computing Inc. 12.40% 88,621 $136K No change
UNBX Unity Biotechnology Inc. 7.38% 49,172 $81K No change

Portfolio Sells Q4 2023 → Q1 2024
None this quarter.

Portfolio Buys Q4 2023 → Q1 2024
NVMI Nova Ltd. New 19.09% +19.09

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q4 2025 2$2.2MRGTI, RFL
Q3 2025 2$2.9MRGTI, RFL
Q2 2025 4$1.4MRGTI, RFL, UNBX, PRCH
Q1 2025 3$1.1MRGTI, RFL, UNBX
Q4 2024 3$1.7MRGTI, CYTH, UNBX
Q3 2024Amended 4$572KCYTH, UNBX, RGTI, NTBLQ
Q2 2024 4$846KCYTH, RGTI, NTBLQ, UNBX
Q1 2024 4$1.1MCYTH, NVMI, RGTI, UNBX